Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anti-inflammatory
Biotech
Biogen inks $1B RayThera buyout to bag immunology assets
The backloaded deal covers a pipeline of anti-inflammatory drug candidates led by a prospect on the cusp of clinical development.
Nick Paul Taylor
Jun 18, 2026 4:10am
Compounds from vaginal bacteria show promise for inflammation
Oct 17, 2024 11:00am
NodThera's NLRP3 inhibitor shows obesity promise in early trial
Jun 12, 2024 7:00am
AbbVie pays $48M for OSE's preclinical chronic inflammation drug
Feb 28, 2024 5:25am
Union says phase 2 results show psoriasis hopeful has wider use
Jun 21, 2023 10:42am
AbbVie links up with VC firm to map anti-inflammatory companies
Nov 28, 2022 7:30am
